Judith M. Matthews - Net Worth and Insider Trading
Judith M. Matthews Net Worth
The estimated net worth of Judith M. Matthews is at least $7,335 dollars as of 2024-05-26. Judith M. Matthews is the CFO of Iterum Therapeutics PLC and owns about 5,433 shares of Iterum Therapeutics PLC (ITRM) stock worth over $7,335. Details can be seen in Judith M. Matthews's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Judith M. Matthews has not made any transactions after 2022-03-14 and currently still holds the listed stock(s).
Transaction Summary of Judith M. Matthews
Judith M. Matthews Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Judith M. Matthews owns 1 companies in total, including Iterum Therapeutics PLC (ITRM) .
Click here to see the complete history of Judith M. Matthews’s form 4 insider trades.
Insider Ownership Summary of Judith M. Matthews
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2022-03-14 | Chief Financial Officer |
Judith M. Matthews Latest Holdings Summary
Judith M. Matthews currently owns a total of 1 stock. Judith M. Matthews owns 5,433 shares of Iterum Therapeutics PLC (ITRM) as of March 14, 2022, with a value of $7,335.
Latest Holdings of Judith M. Matthews
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITRM | Iterum Therapeutics PLC | 2022-03-14 | 5,433 | 1.35 | 7,335 |
Holding Weightings of Judith M. Matthews
Judith M. Matthews Form 4 Trading Tracker
According to the SEC Form 4 filings, Judith M. Matthews has made a total of 4 transactions in Iterum Therapeutics PLC (ITRM) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Iterum Therapeutics PLC is the sale of 3,142 shares on March 14, 2022, which brought Judith M. Matthews around $17,910.
Insider Trading History of Judith M. Matthews
- 1
Judith M. Matthews Trading Performance
GuruFocus tracks the stock performance after each of Judith M. Matthews's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Judith M. Matthews is -16.21%. GuruFocus also compares Judith M. Matthews's trading performance to market benchmark return within the same time period. The performance of stocks bought by Judith M. Matthews within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Judith M. Matthews's insider trading performs compared to the benchmark.
Performance of Judith M. Matthews
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.18 | | | | | |
| Relative Return to S&P 500(%) | -11.97 | | | | | |
Judith M. Matthews Ownership Network
Judith M. Matthews Owned Company Details
What does Iterum Therapeutics PLC do?
Who are the key executives at Iterum Therapeutics PLC?
Judith M. Matthews is the Chief Financial Officer of Iterum Therapeutics PLC. Other key executives at Iterum Therapeutics PLC include Chief Scientific Officer Michael W. Dunne , director & President & CEO Fishman Corey N. , and Chief Medical Officer Sailaja Puttagunta .
Iterum Therapeutics PLC (ITRM) Insider Trades Summary
Over the past 18 months, Judith M. Matthews made no insider transaction in Iterum Therapeutics PLC (ITRM). Other recent insider transactions involving Iterum Therapeutics PLC (ITRM) include a net purchase of 55,000 shares made by Michael W. Dunne , a net purchase of 10,000 shares made by Fishman Corey N. , and a net sale of 3,365 shares made by Sailaja Puttagunta .
In summary, during the past 3 months, insiders sold 0 shares of Iterum Therapeutics PLC (ITRM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,365 shares of Iterum Therapeutics PLC (ITRM) were sold and 65,000 shares were bought by its insiders, resulting in a net purchase of 61,635 shares.
Iterum Therapeutics PLC (ITRM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Iterum Therapeutics PLC Insider Transactions
Judith M. Matthews Mailing Address
Above is the net worth, insider trading, and ownership report for Judith M. Matthews. You might contact Judith M. Matthews via mailing address: 200 West Monroe St., Suite 1575, Chicago Il 60606.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
